Keyphrases
Hepatitis C Virus
100%
Ribavirin
100%
AIDS/HIV
100%
Co-infected Patients
100%
Chronic Hepatitis C
100%
Pegylated Interferon
100%
Virus Hepatitis
100%
Liver Disease
15%
Infected Individual
15%
End-stage Liver Disease
15%
Ropeginterferon alfa-2b
15%
Hepatitis C Virus Therapy
7%
Hepatocellular Carcinoma
7%
Liver Failure
7%
Liver Transplantation
7%
Rapid Progression
7%
Anemia
7%
Stavudine
7%
Zidovudine
7%
Therapeutic Potential
7%
High Incidence
7%
Monoinfection
7%
Highly Active Antiretroviral Therapy (HAART)
7%
Safety Profile
7%
Human Immunodeficiency Virus Infection
7%
Improved Survival
7%
Infected Patients
7%
Potential Therapeutics
7%
Hepatitis C Coinfection
7%
Genotype 2
7%
Deleterious Effects
7%
Viremia
7%
Hepatitis C Virus Genotypes
7%
Virus Diseases
7%
Fast Rates
7%
Sustained Viral Response
7%
Liver Fibrosis Progression
7%
Co-infection
7%
Genotype 3
7%
Anti-hepatitis C Virus
7%
Didanosine
7%
Mitochondrial Toxicity
7%
Medicine and Dentistry
Ribavirin
100%
Hepatitis C Virus
100%
Human Immunodeficiency Virus
100%
Chronic Hepatitis C
100%
Hepatitis Virus
100%
Peginterferon
100%
Virotherapy
13%
Liver Disease
13%
End Stage Liver Disease
13%
Mixed Infection
13%
Liver Transplantation
6%
Hepatocellular Carcinoma
6%
Liver Failure
6%
Human Immunodeficiency Virus Infection
6%
Anemia
6%
Highly Active Antiretroviral Therapy
6%
Virus Infection
6%
Liver Fibrosis
6%
Viremia
6%
Didanosine
6%
Stavudine
6%
Hepatitis C Virus Genotype 1
6%
Zidovudine
6%
Peginterferon Alpha2a
6%
Mitochondrial Toxicity
6%
Peginterferon Alpha2b
6%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Virus Hepatitis
100%
Chronic Hepatitis C
100%
Ribavirin
100%
Hepatitis C Virus
100%
Peginterferon
100%
Liver Disease
13%
End Stage Liver Disease
13%
Mixed Infection
13%
Virotherapy
13%
Human Immunodeficiency Virus Infection
6%
Liver Cell Carcinoma
6%
Anemia
6%
Stavudine
6%
Zidovudine
6%
Virus Infection
6%
Liver Fibrosis
6%
Peginterferon Alpha2a
6%
Liver Failure
6%
Didanosine
6%
Viremia
6%
Hepatitis C Virus Genotype 1
6%
Peginterferon Alpha2b
6%
Mitochondrial Toxicity
6%
Immunology and Microbiology
Hepatitis C Virus
100%
Human Immunodeficiency Virus
100%
Hepatitis Virus
100%
Hepatitis C
100%
Pegylated Interferon
100%
Ribavirin
100%
Virotherapy
13%
Coinfection
13%
Liver Transplantation
6%
Human Immunodeficiency Virus Infection
6%
Viremia
6%
Peginterferon Alfa-2a
6%
Peginterferon Alfa-2b
6%
Sustained Viral Response
6%
Hepatitis C Virus Genotype 1
6%